TENB

Tenable Holdings Inc

Add to Watchlist

Advanced Chart

33.210

+0.14(0.423%)1D

Overview
Forecast
Valuation
Earnings

Line

Candle

YTD

High

33.445

Open

33.210

VWAP

33.17

Vol

839.72K

Mkt Cap

4.06B

Low

32.825

Amount

27.86M

EV/EBITDA(TTM)

131.18

Total Shares

118.87M

3.98B

EV/OCF(TTM)

15.65

P/S(TTM)

4.33

Tenable Holdings, Inc. is an exposure management company. It unifies security visibility, insight and action across this attack surface, equipping modern organizations to expose and close the cybersecurity gaps that erode business value, reputation and trust. The Company’s Tenable One is an AI-powered exposure management platform that gives enterprises a single, unified view of risk across all types of assets and attack pathways. The platform combines broad, vulnerability coverage, spanning information technology (IT) assets, cloud resources, containers, Web apps and identity systems. Tenable One integrates Tenable Vulnerability Management, Tenable Cloud Security, Tenable Identity Exposure, Tenable Web App Scanning, Tenable Lumin Exposure View, Tenable Attack Surface Management, Tenable Security Center and Tenable OT Security. Its Nessus product line deploys vulnerability assessment solutions in the cybersecurity industry and underpins its enterprise platform.

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2025Q4

FY2025Q3

FY2025Q2

250.67M

+6.34%

0.443

+8.05%

243.91M

+7.41%

0.381

+19.03%

242.15M

+9.45%

0.303

-2.32%

Estimates Revision

The market is revising Downward the revenue expectations for Tenable Holdings, Inc. (TENB) for FY2025, with the revenue forecasts being adjusted by -0.38% over the past three months. During the same period, the stock price has changed by 0.70%.

Revenue Estimates for FY2025

Revise Downward

-0.38%

In Past 3 Month

EPS Estimates for FY2025

Revise Downward

-0.53%

In Past 3 Month

Stock Price

Go Up

+0.70%

In Past 3 Month

18 Analyst Rating

10.87% Upside

Wall Street analysts forecast TENB stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for TENB is 36.82 USD with a low forecast of 28.00 USD and a high forecast of 45.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

12 Buy

6 Hold

0 Sell

Moderate Buy

10.87% Upside

Current: 33.210

Low

28.00

Averages

36.82

High

45.00

10.87% Upside

Current: 33.210

Low

28.00

Averages

36.82

High

45.00

Barclays

Equal Weight

maintain

$33 -> $39

2025-07-14

Reason

Barclays

Price Target

$33 -> $39

2025-07-14

maintain

Equal Weight

Reason

Barclays raised the firm's price target on Tenable to $39 from $33 and keeps an Equal Weight rating on the shares. The firm adjusted targets in the security, design, and vertical software-as-a-service group as part of an earnings preview.

UBS

Roger Boyd

Strong Buy

Maintains

$55 → $47

2025-04-23

Reason

UBS

Roger Boyd

Price Target

$55 → $47

2025-04-23

Maintains

Strong Buy

Reason

UBS analyst Roger Boyd lowered the firm's price target on Tenable to $47 from $55 and keeps a Buy rating on the shares.

Morgan Stanley

Hamza Fodderwala

Hold

Maintains

$40 → $30

2025-04-16

Reason

Morgan Stanley

Hamza Fodderwala

Price Target

$40 → $30

2025-04-16

Maintains

Hold

Reason

Morgan Stanley lowered the firm's price target on Tenable to $30 from $40 and keeps an Equal Weight rating on the shares. The firm is adjusting risk/rewards for a large number of software companies as it analyzes tariff risk uncertainty and what has already been priced into shares.

Barclays

Saket Kalia

Hold

Maintains

$48 → $40

2025-04-14

Reason

Barclays

Saket Kalia

Price Target

$48 → $40

2025-04-14

Maintains

Hold

Reason

Barclays lowered the firm's price target on Tenable to $40 from $48 and keeps an Overweight rating on the shares as part of a Q1 preview for 16 on-cycle reporting names in security, design, and vertical software-as-a-service.

Stephens & Co.

Todd Weller

Hold

Initiates

$42

2025-04-01

Reason

Stephens & Co.

Todd Weller

Price Target

$42

2025-04-01

Initiates

Hold

Reason

Stephens analyst Todd Weller initiated coverage of Tenable with an Equal Weight rating and $42 price target. Tenable remains well positioned to continue to execute its strategy of evolving from traditional vulnerability management to a more strategic provider of enterprise manager solutions, the analyst tells investors in a research note. The firm believes sales growth re-acceleration is the most critical factor for the stock. Tenable's current valuation is fair but offers room for upside if the company can execute on growth reacceleration, contends Stephens.

Jefferies

Joseph Gallo

Hold

Maintains

$45 → $37

2025-03-31

Reason

Jefferies

Joseph Gallo

Price Target

$45 → $37

2025-03-31

Maintains

Hold

Reason

See All Ratings

Valuation Metrics

The current forward P/E ratio for Tenable Holdings Inc (TENB.O) is 22.01, compared to its 5-year average forward P/E of 117.84. For a more detailed relative valuation and DCF analysis to assess Tenable Holdings Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

Undervalued

5Y Average PE

117.84

Current PE

22.01

Overvalued PE

207.59

Undervalued PE

28.09

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

Undervalued

5Y Average EV/EBITDA

55.57

Current EV/EBITDA

16.23

Overvalued EV/EBITDA

89.39

Undervalued EV/EBITDA

21.75

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

Undervalued

5Y Average PS

6.59

Current PS

4.12

Overvalued PS

8.15

Undervalued PS

5.03